基于RNA的治疗方法在质瘤中的应用:一篇综述
Mehdi Sanati1, Amir R Afshari2, Seyed Sajad Ahmadi3
1Department of Pharmacology and Toxicology, Faculty of Pharmacy, Birjand University of Medical Sciences, Birjand, Iran; Experimental and Animal Study Center, Birjand University of Medical Sciences, Birjand, Iran.
Progress in molecular biology and translational science
|March 8, 2024
概括
通过向特定的基因,RNA疗法提供了一种有前途的方法来对抗多形质母细胞瘤. 这种策略增强了传统的治疗方法,如化疗和免疫疗法,以获得更好的癌症结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物技术是生物技术.
背景情况:
- 多形质母细胞瘤 (GBM) 由于缺乏向治疗,预后不佳.
- 传统的癌症治疗在专门向癌细胞方面存在局限性.
- 基于RNA的疗法正在成为克服这些局限性的新战略.
研究的目的:
- 提供RNA疗法分类和癌症治疗中的应用的全面概述.
- 阐明基于RNA的抗瘤疗法的机制.
- 总结目前用于癌症的RNA药物的临床状态.
主要方法:
- 在瘤学中基于RNA的治疗方法的文献综述.
- 对抗癌症的RNA治疗机制的分析.
- 调查正在进行的临床试验,涉及用于癌症治疗的RNA药物.
主要成果:
- 基于它们的作用机制,RNA疗法可以被分类.
- 基于RNA的策略显示了向癌细胞治疗的潜力.
- 临床研究表明,针对各种癌症的RNA药物正在不断增加.
结论:
- RNA疗法代表了瘤学的重大进步,特别是对于像GBM这样难以治疗的癌症.
- 基于RNA的策略与传统治疗的整合是一个快速增长的研究领域.
- 进一步的临床研究至关重要,以充分实现RNA药物在癌症治疗中的潜力.
更多相关视频
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
5.7K
11:15Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
7.9K
相关概念视频
02:15Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
02:30siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K